Literature DB >> 20115956

Botox and Dysport: is there a dose conversion ratio in dermatology and aesthetic medicine?

Syrus Karsai, Christian Raulin.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20115956     DOI: 10.1016/j.jaad.2008.12.028

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

Review 1.  Clinical uses of botulinum toxin A in smile aesthetic modification.

Authors:  S N Delpachitra; A W Sklavos; M Dastaran
Journal:  Br Dent J       Date:  2018-09-28       Impact factor: 1.626

2.  A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome.

Authors:  Jane Manning; Peter Dwyer; Anna Rosamilia; Kim Colyvas; Christine Murray; Elizabeth Fitzgerald
Journal:  Int Urogynecol J       Date:  2013-11-26       Impact factor: 2.894

3.  Botulinum Toxin A in the Management of Acne Vulgaris: Evidence and Recommendations.

Authors:  Liam Birkett; Shivani Dhar; Prateush Singh; Afshin Mosahebi
Journal:  Aesthet Surg J       Date:  2022-06-20       Impact factor: 4.485

4.  Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis.

Authors:  Hanan Mohamed El Kahky; Heba Mahmoud Diab; Dalia Gamal Aly; Nehal Magdi Farag
Journal:  Dermatol Res Pract       Date:  2013-10-22

5.  Treatment of symptomatic epidermolysis bullosa simplex with botulinum toxin in a pediatric patient.

Authors:  Heather M Holahan; Ronda S Farah; Nkanyezi N Ferguson; Amy S Paller; Allison A Legler
Journal:  JAAD Case Rep       Date:  2016-07-14

Review 6.  The Practical Use of AbobotulinumtoxinA in Aesthetics.

Authors:  Michael A C Kane; Gary Monheit
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.